Drug Profile
S 18986
Alternative Names: S 18986-1; S18986Latest Information Update: 09 Dec 2010
Price :
$50
*
At a glance
- Originator Cortex Pharmaceuticals
- Developer Servier
- Class Antidementias; Benzothiadiazines; Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action AMPA receptor modulators; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Cognition disorders
Most Recent Events
- 15 Nov 2010 Suspended - Phase-II for Cognition disorders in France (PO)
- 07 Nov 2007 Pharmacodynamics data from a preclinical trial in cognitive impairment presented at the 37th Annual Meeting of the Society for Neuroscience (SFN-2007) ,
- 29 Jul 2004 Pharmacodynamics and pharmacokinetics data presented at the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2004) ,,